Vanda Pharmaceuticals Inc. cotiza a 4.30 USD y tiene una capitalización bursátil de $260M. En los últimos 12 meses ha facturado $216M con un margen de flujo de caja libre del -51.1%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs worldwide. The company's commercial portfolio includes Fanapt for the acute treatment of manic or mixed episodes associated with bipolar I disorder and the treatment…
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $-1.04 | $-0.82 | $-2.39 |
| Estimado | $-0.68 | $-0.59 | $-0.69 | $-1.32 |
| Sorpresa | — | -76.3% | -18.8% | -81.1% |
| Métrica | VNDA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 94.0% | 57.0% | +36.9% |
| Operating Margin | -70.0% | -38.6% | -31.3% |
| Net Margin | -102.0% | -33.6% | -68.5% |
| FCF Margin | -51.1% | -13.9% | -37.2% |
| ROE | -67.4% | -40.4% | -27.0% |
| ROA | -45.1% | -32.0% | -13.1% |
| Current Ratio | 2.39 | 2.84 | -0.45 |
| Debt / Equity | — | 0.28 | — |